• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支气管肺发育不良:原始描述 50 年后。

Bronchopulmonary Dysplasia: 50 Years after the Original Description.

机构信息

Division of Neonatology, Department of Pediatrics, University of Miami Miller School of Medicine, Miami, Florida, USA,

Division of Neonatology, Department of Pediatrics, University of Miami Miller School of Medicine, Miami, Florida, USA.

出版信息

Neonatology. 2019;115(4):384-391. doi: 10.1159/000497422. Epub 2019 Apr 11.

DOI:10.1159/000497422
PMID:30974430
Abstract

Bronchopulmonary dysplasia (BPD) is one of the few diseases in neonatal medicine that has continued to evolve since its first description about 50 years ago. Over these years, advancements in neonatal medicine such as antenatal steroids and exogenous surfactant therapy have significantly reduced neonatal mortality and lowered the limits of viability for preterm infants. Although the incidence of BPD continues to be high, especially in extremely low birth weight infants, the clinical picture has evolved into a milder disease with low mortality or significant morbidities. This new BPD is the result of complex interactions between altered alveolar and vascular development, injury by ante- and postnatal pathogenic factors, and reparative processes in the lung. There has been significant progress in our understanding of risk factors for BPD, but challenges persist in its definition, and in finding effective preventive strategies. There are promising developments with newer preventive interventions such as mesenchymal stem cells, exosomes, immunomodulators, and growth factors, but they are still in preclinical stage. The future challenges include finding ways to define BPD based on the severity of lung pathology, which can better predict long-term outcomes, development of early predictors of lung disease, and finding innovative and evidence-based preventive and management strategies.

摘要

支气管肺发育不良(BPD)是新生儿医学中少数几种自 50 年前首次描述以来仍在不断发展的疾病之一。多年来,产前类固醇和外源性表面活性剂治疗等新生儿医学的进步显著降低了新生儿死亡率,并降低了早产儿的生存极限。尽管 BPD 的发病率仍然很高,尤其是极低出生体重儿,但临床情况已演变为一种更温和的疾病,死亡率较低或存在重大的发病率。这种新的 BPD 是肺泡和血管发育改变、产前和产后致病因素损伤以及肺部修复过程之间复杂相互作用的结果。我们对 BPD 的危险因素有了重大的认识进展,但在其定义和寻找有效的预防策略方面仍存在挑战。一些新的预防干预措施如间充质干细胞、外泌体、免疫调节剂和生长因子方面有了有希望的进展,但它们仍处于临床前阶段。未来的挑战包括找到基于肺病理学严重程度定义 BPD 的方法,这可以更好地预测长期结果,开发肺部疾病的早期预测指标,并找到创新的、基于证据的预防和管理策略。

相似文献

1
Bronchopulmonary Dysplasia: 50 Years after the Original Description.支气管肺发育不良:原始描述 50 年后。
Neonatology. 2019;115(4):384-391. doi: 10.1159/000497422. Epub 2019 Apr 11.
2
Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.吸入或滴注类固醇用于预防支气管肺发育不良。
Neonatology. 2015;107(4):358-9. doi: 10.1159/000381132. Epub 2015 Jun 5.
3
Bronchopulmonary dysplasia: clinical perspective.支气管肺发育不良:临床视角
Birth Defects Res A Clin Mol Teratol. 2014 Mar;100(3):134-44. doi: 10.1002/bdra.23229. Epub 2014 Feb 27.
4
Prevention of bronchopulmonary dysplasia: current strategies.支气管肺发育不良的预防:当前策略
Zhongguo Dang Dai Er Ke Za Zhi. 2017 Aug;19(8):841-851. doi: 10.7499/j.issn.1008-8830.2017.08.001.
5
Prevention and management of bronchopulmonary dysplasia: Lessons learned from the neonatal research network.支气管肺发育不良的预防与管理:从新生儿研究网络中汲取的经验教训。
Semin Perinatol. 2016 Oct;40(6):348-355. doi: 10.1053/j.semperi.2016.05.010.
6
Prevention of bronchopulmonary dysplasia in extremely low gestational age neonates: current evidence.预防极低胎龄早产儿支气管肺发育不良:现有证据。
Arch Dis Child Fetal Neonatal Ed. 2018 May;103(3):F285-F291. doi: 10.1136/archdischild-2017-314264. Epub 2018 Jan 23.
7
Mechanisms of Lung Injury and Bronchopulmonary Dysplasia.肺损伤与支气管肺发育不良的机制
Am J Perinatol. 2016 Sep;33(11):1076-8. doi: 10.1055/s-0036-1586107. Epub 2016 Sep 7.
8
Surfactant, steroids and non-invasive ventilation in the prevention of BPD.表面活性物质、类固醇和无创通气在预防 BPD 中的作用。
Semin Perinatol. 2018 Nov;42(7):444-452. doi: 10.1053/j.semperi.2018.09.006. Epub 2018 Oct 2.
9
Insulin-like growth factor-1 replacement therapy after extremely premature birth: An opportunity to optimize lifelong lung health by preserving the natural sequence of lung development.胰岛素样生长因子-1 替代疗法治疗极早产儿:通过维持肺发育的自然顺序来优化终生肺健康的机会。
Paediatr Respir Rev. 2023 Dec;48:24-29. doi: 10.1016/j.prrv.2023.05.001. Epub 2023 May 6.
10
Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis.布地奈德-表面活性剂气管内给药预防极低出生体重儿支气管肺发育不良:一项系统评价和荟萃分析
Pediatr Pulmonol. 2017 Jul;52(7):968-975. doi: 10.1002/ppul.23680. Epub 2017 Feb 6.

引用本文的文献

1
Variability in the Deformability of Red Blood Cells: Application to Treating Premature Newborns with Blood Transfusion.红细胞变形性的变异性:在治疗早产新生儿输血中的应用。
Int J Mol Sci. 2025 Aug 22;26(17):8144. doi: 10.3390/ijms26178144.
2
Double hit of foetal growth restriction and postnatal hyperoxia alters lung structure and function in a preterm rabbit model of bronchopulmonary dysplasia.胎儿生长受限和出生后高氧双重打击改变支气管肺发育不良早产兔模型的肺结构和功能。
PLoS One. 2025 Aug 26;20(8):e0330717. doi: 10.1371/journal.pone.0330717. eCollection 2025.
3
Sex, hormones, and lung health.
性别、激素与肺部健康。
Physiol Rev. 2025 Aug 6. doi: 10.1152/physrev.00026.2024.
4
Genetic variation in the activity of a TREM2-p53 signaling axis determines oxygen-induced lung injury.TREM2-p53信号轴活性的基因变异决定了氧诱导的肺损伤。
Nat Immunol. 2025 Jul 25. doi: 10.1038/s41590-025-02217-4.
5
Characterization of hyperoxia-induced senescent lung macrophages in neonatal mice.新生小鼠高氧诱导衰老肺巨噬细胞的特征分析
bioRxiv. 2025 May 10:2025.05.09.652066. doi: 10.1101/2025.05.09.652066.
6
Research progress on pathophysiologic mechanisms, clinical treatment and predictive biomarkers in bronchopulmonary dysplasia: from the perspective of oxidative stress.支气管肺发育不良的病理生理机制、临床治疗及预测性生物标志物的研究进展:基于氧化应激视角
Front Pediatr. 2025 Mar 27;12:1343870. doi: 10.3389/fped.2024.1343870. eCollection 2024.
7
The tryptophan metabolite 3-hydroxyanthranilic acid alleviates hyperoxia-induced bronchopulmonary dysplasia via inhibiting ferroptosis.色氨酸代谢产物3-羟基邻氨基苯甲酸通过抑制铁死亡减轻高氧诱导的支气管肺发育不良。
Redox Biol. 2025 May;82:103579. doi: 10.1016/j.redox.2025.103579. Epub 2025 Mar 8.
8
Development of CPAP Overlay Interfaces for Efficient Administration of Aerosol Surfactant Therapy to Preterm Infants.用于向早产儿高效给予气溶胶表面活性剂疗法的持续气道正压通气覆盖接口的研发
AAPS PharmSciTech. 2025 Jan 16;26(1):34. doi: 10.1208/s12249-024-02987-4.
9
Artificial womb technology - A more physiologic solution to treating extreme prematurity.人工子宫技术——治疗极早产儿的更生理性解决方案。
Eur J Obstet Gynecol Reprod Biol X. 2024 Dec 15;25:100359. doi: 10.1016/j.eurox.2024.100359. eCollection 2025 Mar.
10
Endothelial Cpt1a Inhibits Neonatal Hyperoxia-Induced Pulmonary Vascular Remodeling by Repressing Endothelial-Mesenchymal Transition.内皮细胞Cpt1a通过抑制内皮-间充质转化来抑制新生儿高氧诱导的肺血管重塑。
Adv Sci (Weinh). 2025 Mar;12(11):e2415824. doi: 10.1002/advs.202415824. Epub 2025 Jan 12.